BioMarin Pharmaceutical
BMRN
#1885
Rank
S$13.90 B
Marketcap
S$71.79
Share price
-0.16%
Change (1 day)
4.75%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): S$1.05

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is S$0.49. In 2022 the company made an earnings per share (EPS) of S$0.98 an increase over its 2021 EPS that were of S-$0.45.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$1.056.59%
2022S$0.98-319.62%
2021S-$0.45-107.38%
2020S$6.07-3485.71%
2019S-$0.18-67.44%
2018S-$0.55-34.85%
2017S-$0.85-83.21%
2016S-$5.04263.89%
2015S-$1.3818.68%
2014S-$1.17-28.91%
2013S-$1.6434.74%
2012S-$1.2293.88%
2011S-$0.63-124.5%
2010S$2.56
2009N/A-100%
2008S$0.41-300%
2007S-$0.21-54.29%
2006S-$0.45-67.89%
2005S-$1.40-62.54%
2004S-$3.73136.59%
2003S-$1.58-15.17%
2002S-$1.86-11.59%
2001S-$2.1056.19%
2000S-$1.3510.53%
1999S-$1.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
S$2.44 400.77%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
S-$7.48-1,636.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S-$0.49-200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.02563-105.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S-$0.14-128.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$2.32 376.32%๐Ÿ‡บ๐Ÿ‡ธ USA